Soleno Therapeutics (SLNO) Debt to Equity: 2013-2015
Historic Debt to Equity for Soleno Therapeutics (SLNO) over the last 1 years, with Dec 2015 value amounting to $0.27.
- Soleno Therapeutics' Debt to Equity rose 3057.22% to $0.27 in Q4 2015 from the same period last year, while for Dec 2015 it was $0.27, marking a year-over-year increase of 3057.22%. This contributed to the annual value of $0.27 for FY2015, which is 3057.22% up from last year.
- According to the latest figures from Q4 2015, Soleno Therapeutics' Debt to Equity is $0.27, which was up 108.99% from -$2.98 recorded in Q3 2015.
- Soleno Therapeutics' Debt to Equity's 5-year high stood at $0.27 during Q4 2015, with a 5-year trough of -$2.98 in Q3 2015.
- Over the past 3 years, Soleno Therapeutics' median Debt to Equity value was -$0.41 (recorded in 2013), while the average stood at -$0.92.
- Data for Soleno Therapeutics' Debt to Equity shows a peak YoY spiked of 3,057.22% (in 2015) over the last 5 years.
- Over the past 3 years, Soleno Therapeutics' Debt to Equity (Quarterly) stood at -$0.41 in 2013, then spiked by 97.78% to -$0.01 in 2014, then soared by 3,057.22% to $0.27 in 2015.
- Its Debt to Equity was $0.27 in Q4 2015, compared to -$2.98 in Q3 2015 and -$1.44 in Q2 2015.